SpineGuard Looks to Break Even by 2018, Names Co-Founder CEO Post author:Sam Post published:July 6, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Incyte Discloses Promising New Data in Combo Drug Trial With Merck & Co.'s Keytruda August 30, 2017 Zoetis Announces Second Quarter 2017 Results August 7, 2017 Data To Be Presented At Highlighting GENFIT???s Latest Progress In NASH Biomarker Diagnostics, Identifying Novel Compounds With Potent Antifibrotic Properties, And Illustrating The Opportunities In Anti-NASH Drug Combinations April 4, 2017
Data To Be Presented At Highlighting GENFIT???s Latest Progress In NASH Biomarker Diagnostics, Identifying Novel Compounds With Potent Antifibrotic Properties, And Illustrating The Opportunities In Anti-NASH Drug Combinations April 4, 2017